Correlation Between Eargo, and Neuropace
Can any of the company-specific risk be diversified away by investing in both Eargo, and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eargo, and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eargo, Inc and Neuropace, you can compare the effects of market volatilities on Eargo, and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eargo, with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eargo, and Neuropace.
Diversification Opportunities for Eargo, and Neuropace
Pay attention - limited upside
The 3 months correlation between Eargo, and Neuropace is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Eargo, Inc and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Eargo, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eargo, Inc are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Eargo, i.e., Eargo, and Neuropace go up and down completely randomly.
Pair Corralation between Eargo, and Neuropace
Considering the 90-day investment horizon Eargo, Inc is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Eargo, Inc is 1.1 times less risky than Neuropace. The stock trades about -0.11 of its potential returns per unit of risk. The Neuropace is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 164.00 in Neuropace on September 6, 2024 and sell it today you would earn a total of 955.00 from holding Neuropace or generate 582.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 30.3% |
Values | Daily Returns |
Eargo, Inc vs. Neuropace
Performance |
Timeline |
Eargo, Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neuropace |
Eargo, and Neuropace Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eargo, and Neuropace
The main advantage of trading using opposite Eargo, and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eargo, position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.The idea behind Eargo, Inc and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |